Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma
Authors
Keywords
Immunotherapy, GBM, ADC, MRI, Pseudoprogression
Journal
NEURORADIOLOGY
Volume 59, Issue 2, Pages 135-145
Publisher
Springer Nature
Online
2017-01-09
DOI
10.1007/s00234-016-1769-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
- (2015) A.J. Prager et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma
- (2015) Andrew Elson et al. JOURNAL OF NEURO-ONCOLOGY
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
- (2015) Hideho Okada et al. LANCET ONCOLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
- (2015) D. A. Reardon et al. Cancer Immunology Research
- A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas
- (2014) A. Hilario et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Impact of imaging measurements on response assessment in glioblastoma clinical trials
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma
- (2014) Peter S. LaViolette et al. NEURO-ONCOLOGY
- Diffusion Imaging for Tumor Grading of Supratentorial Brain Tumors in the First Year of Life
- (2013) S. F. Kralik et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression after glioma therapy: a comprehensive review
- (2013) Tim J Kruser et al. Expert Review of Neurotherapeutics
- Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival
- (2013) Christina Chen et al. JOURNAL OF NEURO-ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging
- (2013) Hee Ho Chu et al. RADIOLOGY
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas Are Associated with Improved Survival Compared with Matched Controls
- (2012) S. Mong et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI
- (2012) M. J. Wieduwilt et al. CLINICAL CANCER RESEARCH
- Isolated Diffusion Restriction Precedes the Development of Enhancing Tumor in a Subset of Patients with Glioblastoma
- (2011) A. Gupta et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
- (2011) L.C. Hygino da Cruz et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Mechanisms of immunomodulation in human glioblastoma
- (2011) Tony Avril et al. Immunotherapy
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study
- (2010) Matej Vrabec et al. NEURORADIOLOGY
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient at MR imaging
- (2009) Fumiyuki Yamasaki et al. EUROPEAN JOURNAL OF RADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started